Boehringer's obesity drug shows 16.6% weight loss; more data needed

Summary: There is a new player in the weight-loss world! Boehringer has a new drug that helped people lose 16.6% of their body weight, though scientists still need to see more data to be sure. In totally unrelated but crazy news, a completely botched football kick might have actually saved someone's life!

Meanwhile, there is massive drama happening with the FDA. The agency is trying to force Amgen to pull its rare-disease drug, Tavneos, off the market. The FDA says the drug doesn't work and that Amgen's paperwork contained untrue statements, but Amgen is flat-out refusing to take it off the shelves. In the futuristic science department, Eli Lilly is teaming up with an AI company named Profluent to build new gene editors that could drop entire, complete genes right into patients.

For more details, see rssapp-statnews-com at statnews.com/2026/04/28/biotech-news-boehringer-drug-looks-efficacious-but-more-data-needed/ (opens in new tab)